Canada’s Drug Agency/L’Agence des médicaments du Canada (CDA-AMC) has launched a consultation on advice for a national bulk purchasing strategy for prescription drugs and related products. Notably, the advice proposes making the pan-Canadian Pharmaceutical Alliance (pCPA)
July 2025
Drug Pricing Update: PMPRB releases final price-review Guidelines


By Christopher A. Guerreiro & Kristin Wall on
On June 30, 2025, the Patented Medicine Prices Review Board (PMPRB or Board) released the final version of its new guidelines (the Guidelines).
The Guidelines outline a new process for Board Staff to evaluate and make hearing…